Label: URICALM MAXIMUM STRENGTH- phenazopyridine hydochloride tablet, film coated
-
NDC Code(s):
52389-241-01,
52389-241-02,
52389-241-03,
52389-241-04, view more52389-241-12, 52389-241-24, 52389-241-28, 52389-241-36, 52389-241-48
- Packager: Kobayashi Healthcare International, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated November 15, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each tablet)
- Purpose
- Uses
- Warnings
- Do not use if you have
- When using this product
- ASK DOCTOR/PHARMACIST
- Stop use and ask a doctor if
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
-
Directions
- Read all package directions and warnings before use.
- Use only as directed.
- Do not exceed recommended dosage.
- Adults: Swallow two (2) tablets with water after meals as needed up to 3 times daily for 2 days maximum.
- Swallow whole. Do not crush or chew.
- Do not use more than 12 tablets in 2 days.
- Drink 6 to 8 eight glasses of water daily.
- For use by normally healthy adults only. Persons under 18 years of age should use only as directed by a doctor.
-
Other information
WARNING: this product contains a chemical known to the State of California to cause cancer. Precaution: Carcinogenesis: Long-term administration of phenazopyridine HCl has induced neoplasia in rats (large intestine) and mice (liver) . Although no association between phenazopyridine HCl and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted. **Contents sealed: Each URICALM dark red colored, round shaped tablet bears the identifying mark "ALVA" and a "1" on the reverse side, and is sealed in a clear plastic blister with with foil backing. Do not use if seal appears broken or if product contents do not match product description. This product may stain soft contact lenses. This product can interfere with laboratory tests including urine, glucose (sugar) and ketones. You may report serious side effects to the phone number provided under Questions? below.
-
Inactive ingredients
Carmine, Cornstarch, Cranberry Fruit Powder, Croscarmellose Sodium, FD&C Red No. 40 Lake, FD&C Yellow No. 6 Lake, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Maltodextrin, Mineral Oil, Polyethylene Glycol, Polyvinylpyrrolidone, Pregelatinized Starch, Silicon Dioxide, Talc, Titanium Dioxide and Triacetin.
- QUESTIONS
-
Product Insert
Uricalm
199 mg Strong per dose
The Highest Dose of Clinically Proven Phenazopyridine Hydrochloride Available Over the Counter, Plus Cranberry
URICALM provides the maximum non-prescription strength of clinically proven Phenazopyridine Hydrochloride to relieve pain, burning, increased frequency, and sensation of urgency associated with urinary tract infections. Phenazopyridine Hydrochloride is the #1 doctor recommended ingredient for fast relief of UTI pain. Plus, URICALM contains cranberry, which is used extensively by those concerned about urinary tract health.
Active ingredient (in each tablet):Phenazopyridine Hydrochloride 99.5 mg
Purpose: Urinary analgesic
Uses: Prompt temporary relief of
- pain during urination
- burning
- sensation of urgency
- increased frequency associated with urinary tract infections.
Warnings
Do not use if you have
- liver or kidney problems
- allergies to foods, preservatives or dyes
- had a hypersensitive reaction to phenazopyridine hydrochloride
When using this product
- stomach upset may occur; taking this product with or after meals may reduce stomach upset
- you may experience a reddish-orange discoloration of the urine which is a non-harmful temporary effect.
Ask a doctor or pharmacist before use if you are taking any other medications.
Stop use and ask a doctor if
- your symptoms do not go away after two days or become worse
- you experience fever, chills, back pain or bloody urine.
- you suspect you are having an adverse reaction to this medication
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a poison control center right away.
Directions:
- Read all package directions and warnings before use.
- Use only as directed.
- Do not exceed recommended dosage.
- Adults: Swallow two (2) tablets with water after meals as needed up to 3 times daily for 2 days maximum.
- Swallow whole. Do not crush or chew.
- Do not use more than 12 tablets in 2 days
- Drink 6 to 8 glasses of water daily.
- For use by normally healthy persons only. Persons under 18 years of age should use only as directed by a doctor.
Other information: WARNING: This product contains a chemical known to the State of California to cause cancer. Precaution: Carcinogenesis: Long-term administration of phenazopyridine HCl has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine HCl and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted.
**Contents sealed: Each URICALM dark red colored, round shaped tablet bears the identifying mark "ALVA" and a "1" on the reverse side, and is sealed in a clear plastic blister with foil backing. Do not use if seal appears broken or if product contents do not match product description. This product may stain soft contact lenses. This product can interfere with laboratory tests including urine, glucose (sugar) and ketones. You may report serious side effects to the phone number provided under Questions? below.
Inactive ingredients:Carmine, corn starch, cranberry fruit powder, croscarmellose sodium, FD&C Red No. 40 Lake, FD&C Yellow No. 6 Lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, talc, titanium dioxide and triacetin.
Questions? 1-800-792-2582
www.URICALM.com
Uricalm
199 mg de concentración por dosis
Contiene la dosis más alta de phenazopyridine hydrochloride clínicamente comprobado disponible en venta sin receta, además de arándano
URICALM ofrece la dosis más alta de chlorhidrato de fenazopyridina clínicamente comprobado de venta sin receta para aliviar el dolor, el ardor, el aumento en la frequencia y la sensación de necesidad urgente de orinar asociados con las infecciones del tracto urinario. El chlorhidrato de fenazopiridina es el ingrediente N. o 1 recomendado por el médico para el alivio rápido del dolor causado por las infecciones del tracto urinario (UTI, por sus singlas en ingles). Además, URICALM contiene arándano, que es usado ampliamente por quienes se preocupan por la salud del tracto urinario.
Ingrediente activo (in cada tableta): Phenazopyridine hydrochloride 99.5 mg
Propósito: Analgésico urinario
Usos: Alivio rápido y temporal del
- dolor durante la micción
- del ardor
- de la sensación de necesidad urgente de orinar
- del aumento en la frecuencia asociada con las infecciones del tracto urinario.
Advertencias:
No lo use si tiene
- problemos hepático o renales
- alergias a los alimentos, conservantes o colorantes
- ha tenido una reacción hipersensible al phenazopyridine hydrochloride
Cuando se use este producto
- puede presentarse malestar estomical; la ingestión de este producto con alimentos o después de comer puede reducir el malestar estomacal
- puede experimentar un color de rojizo a anaranjado en la orina, lo cual es un efecto temporal inofensivo.
Consulte con un médico o farmacéutico antes de usarlo si está tomando cualquier otro medicamento.
Interrumpa el uso y consulte con su médico si
- los síntomas no desaparecen o empeoran después de dos dias
- tiene fiebre, escalofríos, dolor de espalda o nota la presencia de sangre en la orina.
- sospecha que está experimentado una reacción adversa a este medicamento.
Si está embarazada o lactando, consulte con un profesional de la salud antes de usario.
Manténgalo fuera del alcance de los niños. En caso de sobredosis, obtenga ayuda médica o comuníquese de inmediato con un centro de toxicologia.
Indicaciones:
- Lea todos las indicaciones y advertencias en el envase antes de usarlos.
- Úselo únicamente como se indica.
- No exceda la dosis recomendada.
- Adultos: Ingiera dos (2) tabletas con agua después de las comidas según sea necesario hasta 3 veces al día por un máximo de 2 dias.
- Trague la tablets entera. No triture ni mastique la tableta.
- No use más de 12 tabletas en 2 días.
- Tome de 6 a 8 vasos de agua todos los dias.
- Para usarlo en adultos normalmente sanos únicamente. Las personas menores de 18 años deben usarlo solo según las indicaciones de un médico.
Información adicional: ADVERTENCIA: Este producto contiene una sustancia quimica que en el Estado de California se sabe que causa cáncer. Precaución: Carcinogénesis: La administración a largo plazo del phenazopyridine hydrochloride ha inducido neoplasia en ratas (intestino grueso) y en ratones (hígado). Aunque no ha sido informada una asociación entre el phenazopyridine hydrochloride y la neoplasia en seres humanos, no se han realizado estudios epidemiológicos adecuados sobre esto.
**El contenido está sellado Cada tableta URICALM de color rojo oscuro y redonda lleva la marca identificadora "ALVA" y un "1" en el dorso, y está sellada en un blíster de plástico transperente con un recubrimiento posterior de papel aluminio. No lo use si el sello parece estar roto o si el producto no coincide con la descripción del producto. Este producto puede causar manchas en los lentes de contacto blandos. Este producto puede interferir con las pruebas de laboratorio incluidas orina, glucosa (azúcar) y cetonas. Puede informar efectos secundarios graves al número de teléfono que aparece en la sección ¿Tiene preguntas? a continuación.
Ingredientes inactivos: carmin, almidón de maíz, polvo de la fruta de arándano, croscarmelosa sódica, FD&C Rojo No. 40 Lake, FD&C Amarillo No. 6 lake, hipromelosa, estearato de magnesio, maltodextrina, celulosa microcristalina, aceite mineral, polietilenglicol, polivinilpirrolidona, almidón pregelatinizado, dióxido de silicio, talco, dióxido de titanio y tracetino.
¿Tiene preguntas? 1-800-792-2582
www.URICALM.com
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
URICALM MAXIMUM STRENGTH
phenazopyridine hydochloride tablet, film coatedProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:52389-241 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52) PHENAZOPYRIDINE HYDROCHLORIDE 99.5 mg Inactive Ingredients Ingredient Name Strength COCHINEAL (UNII: TZ8Z31B35M) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) HYPROMELLOSES (UNII: 3NXW29V3WO) LIGHT MINERAL OIL (UNII: N6K5787QVP) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FD&C RED NO. 40 (UNII: WZB9127XOA) TRIACETIN (UNII: XHX3C3X673) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) MAGNESIUM STEARATE (UNII: 70097M6I30) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) POVIDONE (UNII: FZ989GH94E) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) TALC (UNII: 7SEV7J4R1U) STARCH, CORN (UNII: O8232NY3SJ) CRANBERRY (UNII: 0MVO31Q3QS) MALTODEXTRIN (UNII: 7CVR7L4A2D) Product Characteristics Color red Score no score Shape ROUND Size 7mm Flavor Imprint Code ALVA;1 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:52389-241-24 1 in 1 CARTON 04/29/2008 1 NDC:52389-241-01 24 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:52389-241-12 1 in 1 CARTON 08/01/2009 12/31/2011 2 NDC:52389-241-02 12 in 1 BLISTER PACK; Type 0: Not a Combination Product 3 NDC:52389-241-36 1 in 1 CARTON 07/15/2012 06/15/2013 3 NDC:52389-241-03 36 in 1 BLISTER PACK; Type 0: Not a Combination Product 4 NDC:52389-241-28 1 in 1 CARTON 02/20/2014 4 NDC:52389-241-04 28 in 1 BLISTER PACK; Type 0: Not a Combination Product 5 NDC:52389-241-48 2 in 1 CARTON 10/18/2021 5 24 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 04/29/2008 Labeler - Kobayashi Healthcare International, Inc. (156391729) Registrant - Kobayashi America Manufacturing, LLC (079852150)